CELC
Price
$53.57
Change
+$2.34 (+4.57%)
Updated
Sep 2, 04:59 PM (EDT)
Capitalization
2.17B
76 days until earnings call
CLDX
Price
$22.06
Change
-$0.02 (-0.09%)
Updated
Sep 2, 04:59 PM (EDT)
Capitalization
1.47B
64 days until earnings call
Interact to see
Advertisement

CELC vs CLDX

Header iconCELC vs CLDX Comparison
Open Charts CELC vs CLDXBanner chart's image
Celcuity
Price$53.57
Change+$2.34 (+4.57%)
Volume$6.47K
Capitalization2.17B
Celldex Therapeutics
Price$22.06
Change-$0.02 (-0.09%)
Volume$58.81K
Capitalization1.47B
CELC vs CLDX Comparison Chart in %
Loading...
CELC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CLDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CELC vs. CLDX commentary
Sep 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CELC is a Buy and CLDX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 03, 2025
Stock price -- (CELC: $51.23 vs. CLDX: $22.08)
Brand notoriety: CELC and CLDX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CELC: 48% vs. CLDX: 114%
Market capitalization -- CELC: $2.17B vs. CLDX: $1.47B
CELC [@Biotechnology] is valued at $2.17B. CLDX’s [@Biotechnology] market capitalization is $1.47B. The market cap for tickers in the [@Biotechnology] industry ranges from $100.25B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CELC’s FA Score shows that 1 FA rating(s) are green whileCLDX’s FA Score has 0 green FA rating(s).

  • CELC’s FA Score: 1 green, 4 red.
  • CLDX’s FA Score: 0 green, 5 red.
According to our system of comparison, CELC is a better buy in the long-term than CLDX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CELC’s TA Score shows that 2 TA indicator(s) are bullish while CLDX’s TA Score has 3 bullish TA indicator(s).

  • CELC’s TA Score: 2 bullish, 6 bearish.
  • CLDX’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, CLDX is a better buy in the short-term than CELC.

Price Growth

CELC (@Biotechnology) experienced а -2.27% price change this week, while CLDX (@Biotechnology) price change was -1.69% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.83%. For the same industry, the average monthly price growth was +22.37%, and the average quarterly price growth was +32.94%.

Reported Earning Dates

CELC is expected to report earnings on Nov 17, 2025.

CLDX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+6.83% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CELC($2.17B) has a higher market cap than CLDX($1.47B). CELC YTD gains are higher at: 291.367 vs. CLDX (-12.624). CELC has higher annual earnings (EBITDA): -135.56M vs. CLDX (-231.4M). CLDX has more cash in the bank: 630M vs. CELC (168M). CLDX has less debt than CELC: CLDX (3.03M) vs CELC (99.4M). CLDX has higher revenues than CELC: CLDX (5.79M) vs CELC (0).
CELCCLDXCELC / CLDX
Capitalization2.17B1.47B148%
EBITDA-135.56M-231.4M59%
Gain YTD291.367-12.624-2,308%
P/E RatioN/AN/A-
Revenue05.79M-
Total Cash168M630M27%
Total Debt99.4M3.03M3,279%
FUNDAMENTALS RATINGS
CELC vs CLDX: Fundamental Ratings
CELC
CLDX
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
57
Fair valued
PROFIT vs RISK RATING
1..100
2578
SMR RATING
1..100
9997
PRICE GROWTH RATING
1..100
3461
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CLDX's Valuation (57) in the Biotechnology industry is in the same range as CELC (85) in the Miscellaneous Commercial Services industry. This means that CLDX’s stock grew similarly to CELC’s over the last 12 months.

CELC's Profit vs Risk Rating (25) in the Miscellaneous Commercial Services industry is somewhat better than the same rating for CLDX (78) in the Biotechnology industry. This means that CELC’s stock grew somewhat faster than CLDX’s over the last 12 months.

CLDX's SMR Rating (97) in the Biotechnology industry is in the same range as CELC (99) in the Miscellaneous Commercial Services industry. This means that CLDX’s stock grew similarly to CELC’s over the last 12 months.

CELC's Price Growth Rating (34) in the Miscellaneous Commercial Services industry is in the same range as CLDX (61) in the Biotechnology industry. This means that CELC’s stock grew similarly to CLDX’s over the last 12 months.

CELC's P/E Growth Rating (100) in the Miscellaneous Commercial Services industry is in the same range as CLDX (100) in the Biotechnology industry. This means that CELC’s stock grew similarly to CLDX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CELCCLDX
RSI
ODDS (%)
Bearish Trend 5 days ago
78%
N/A
Stochastic
ODDS (%)
Bearish Trend 5 days ago
89%
Bearish Trend 5 days ago
80%
Momentum
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
75%
MACD
ODDS (%)
Bearish Trend 5 days ago
77%
Bearish Trend 5 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
86%
Bearish Trend 5 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
81%
Bearish Trend 5 days ago
82%
Advances
ODDS (%)
Bullish Trend 6 days ago
83%
Bullish Trend 12 days ago
82%
Declines
ODDS (%)
Bearish Trend 14 days ago
86%
Bearish Trend 5 days ago
79%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
88%
Bearish Trend 5 days ago
87%
Aroon
ODDS (%)
Bullish Trend 5 days ago
85%
Bullish Trend 5 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
CELC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CLDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AVURX8.500.01
+0.12%
American Century Value R
PGJQX18.10-0.04
-0.22%
PGIM Jennison Global Infrastructure R6
VBPIX22.49-0.15
-0.66%
Vanguard Baillie GiffordGlbPstvImpStkInv
MIGYX64.17-0.44
-0.68%
Invesco Main Street Y
MIOPX31.34-0.28
-0.89%
Morgan Stanley Inst International Opp A

CELC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CELC has been closely correlated with IMA. These tickers have moved in lockstep 86% of the time. This A.I.-generated data suggests there is a high statistical probability that if CELC jumps, then IMA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CELC
1D Price
Change %
CELC100%
-6.17%
IMA - CELC
86%
Closely correlated
-0.45%
NEVPF - CELC
61%
Loosely correlated
N/A
BEAM - CELC
45%
Loosely correlated
-2.91%
CLDX - CELC
44%
Loosely correlated
-1.34%
ABOS - CELC
43%
Loosely correlated
+3.82%
More

CLDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLDX has been loosely correlated with CRNX. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if CLDX jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLDX
1D Price
Change %
CLDX100%
-1.34%
CRNX - CLDX
50%
Loosely correlated
+1.11%
RVMD - CLDX
49%
Loosely correlated
-0.93%
ARCT - CLDX
49%
Loosely correlated
-1.68%
BEAM - CLDX
49%
Loosely correlated
-2.91%
NRIX - CLDX
48%
Loosely correlated
-0.74%
More